TABLE 1.
Clinicopathological characteristics of six ovarian cancer patients that were treated with neoadjuvant chemotherapy.
Case no. | Age (Year) | FIGO stage | Right (R) and left (L) ovary | Histological diagnosis | Treatment | Clinical response to therapy |
---|---|---|---|---|---|---|
1 | 38 | III | R | HGSOC | Carboplatin + paclitaxel | Progressive disease |
2 | 78 | IV | R | HGSOC | Carboplatin + paclitaxel | Responsive |
3 | 45 | II | R | HGSOC | Carboplatin + paclitaxel | Responsive |
4 | 50 | III | R and L | HGSOC | Carboplatin + paclitaxel | Progressive disease |
5 | 54 | III | R and L | HGSOC | Carboplatin + paclitaxel | Progressive disease (death) |
6 | 68 | IV | R | HGSOC | Carboplatin + paclitaxel | Progressive disease (death) |